Please assess the completion status of the following clinical trial:

Trial Title: Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: FACTORIAL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE1/PHASE2
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* ADPKD~* \> 18 y.o. GFR greater than or equal to 25. Willingness to be randomized to any treatment group Willingness to follow protocol requirements-frequent testing and follow-up required at Cleveland Clinic(Cleveland, OH) signed informed consent Willingness to use birth control(male and female)~Exclusion Criteria:~* Pregnancy~* post partum~* lactating~* system illness with renal involvement

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Arm 1 Rapamune dose 2-6mg aimed at maintaining trough levels 5-8 ng/ml
- 2 (Type: EXPERIMENTAL): Arm 2 Rapamune dose 2-6 mg aimed at maintaining trough levels of 2-5ng/ml
- 3 (Type: NO_INTERVENTION): Standard Care

Based on this trial design, predict the completion outcome and termination type (if applicable).